Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.
Open Access
- 1 May 1994
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 57 (5), 562-566
- https://doi.org/10.1136/jnnp.57.5.562
Abstract
The motor responses of 14 patients with Parkinson's disease (six previously untreated and eight chronically receiving levodopa) with pronounced asymmetry in the severity of motor signs between the left and right sides of the body were studied. The effects of a short (60 minutes) and a long (16-22 hours) intravenous levodopa infusion as well as of subcutaneous apomorphine (1-6 mg bolus) were assessed. Four different tapping tests were used to measure motor function. For all pharmacological tests, the more affected side showed a shorter response duration, increased latency, and greater response magnitude than the less affected side. These differences were more pronounced in those patients receiving chronic levodopa treatment. As apomorphine is not dependent on dopamine storage capacity, these findings suggest that postsynaptic mechanisms play an important part in the origin of motor fluctuations in Parkinson's disease.Keywords
This publication has 22 references indexed in Scilit:
- SUBCUTANEOUS LISURIDE INFUSION IN PARKINSON'S DISEASEBrain, 1991
- Which risk factors predict the levodopa response in fluctuating Parkinson's disease?Annals of Neurology, 1990
- Peripheral pharmacokinetics of apomorphine in humansAnnals of Neurology, 1989
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part IAnnals of Neurology, 1988
- Progress in understanding the pathophysiology of treatment‐related fluctuations in Parkinson's diseaseAnnals of Neurology, 1988
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part IIAnnals of Neurology, 1988
- Central Mechanisms and Levodopa Response Fluctuations in Parkinsonʼs DiseaseClinical Neuropharmacology, 1988
- SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONSThe Lancet, 1988
- Dopamine D2 receptor density remains constant in treated Parkinson's diseaseAnnals of Neurology, 1986
- Dopamine-sensitive adenylate cyclase activity in the striatum in Parkinson's diseaseJournal of Neural Transmission, 1979